Troponin assay use in the emergency department for management of patients with potential acute coronary syndrome: current use and future directions.
- Author:
William R FOX
1
;
Deborah B DIERCKS
Author Information
- Publication Type:Review
- Keywords: Myocardial infarction; Troponin; Risk stratification; Diagnostic test; Prognosis
- MeSH: Acute Coronary Syndrome*; Chest Pain; Clinical Decision-Making; Diagnostic Tests, Routine; Emergencies*; Emergency Service, Hospital*; Humans; Myocardial Infarction; Myocardial Ischemia; Necrosis; Prognosis; Research Personnel; Troponin*
- From: Clinical and Experimental Emergency Medicine 2016;3(1):1-8
- CountryRepublic of Korea
- Language:English
- Abstract: Troponins are proteins commonly found in cardiac tissue that are released during myocardial ischemia or necrosis. These troponins can be detected by assays that can then be used to guide clinical decision-making and disposition, especially if the suspected insult is related to acute coronary syndrome. Timing of troponin measurement can be important as elevations may not be detectible immediately after an insult. New assays have been designed to detect troponin con-centrations previously too low to be detected by conventional assays. These tests are known as high-sensitivity cardiac troponin assays. Current research is aimed at evaluating the clinical sig-nificance of troponin elevations detected by these new assays especially in management of pa-tients with suspected acute coronary syndrome. A number of risk-stratification scores exist to assist physicians with evaluating chest pain in the emergency department in the context of de-tection (or absence) of troponins in systemic circulation. Additionally, investigators are working to integrate data generated by hs-cTn measurements into existing and new risk-stratification scores.
